2026-10-01 12:20:00 UTC#398549newconfirmednews
PRQR stock news
PRQR stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire10 wire items
2026-09-30 18:07:30 UTC#393588updateconfirmednews
ProQR Therapeutics reports clinical progress for AX-0810 and AX-0811 with €117.1M cash runway
2026-09-30 16:51:22 UTC#393187newconfirmednews
ProQR Therapeutics initiates Phase I trial for AX-0811 in biliary atresia with initial data expected in early 2027
2026-09-23 12:00:00 UTC#355180newconfirmedpress release
ProQR Therapeutics appoints Thomas Wolf to Board of Directors as Strategic AI Advisor
2026-09-23 12:00:00 UTC#355179newconfirmedpress release
ProQR Therapeutics appoints Chris Hart as Chief Data and AI Officer
2026-08-20 13:49:49 UTC#201208duplicateconfirmednews
Bank of America initiates coverage of ProQR Therapeutics with Buy rating
seeking alphaimportance 0.30trust 0.60ProQR Therapeutics N.V. +0.50Bank of America Corporation +0.50
2026-08-20 12:14:00 UTC#200691newconfirmednews
B of A Securities sets $8.00 price target on ProQR Therapeutics (PRQR)
2026-08-13 11:04:00 UTC#171036newconfirmednews
ProQR Therapeutics reports Q2 2026 loss of EUR 0.08 per share
2026-08-13 11:01:00 UTC#171116duplicateconfirmednews
ProQR Therapeutics Reports Q2 2026 Revenue of EUR 8.76M, Beating Estimates, and EPS of EUR -0.08
2026-08-11 12:43:08 UTC#158710newforecastnews